医学
心脏毒性
随机对照试验
乳腺癌
内科学
癌症
射血分数
体质指数
生活质量(医疗保健)
物理疗法
不利影响
肿瘤科
化疗
心力衰竭
护理部
作者
Estíbaliz Díaz-Balboa,Carlos Peña,Beatriz Rodríguez‐Romero,Ántonio Cuesta-Vargas,Óscar Lado‐Baleato,Amparo Martínez‐Monzonís,Milagros Pedreira-Pérez,P. Palacios-Ozores,Rafael López‐López,José Ramón González‐Juanatey,Violeta González‐Salvado
标识
DOI:10.1016/j.pcad.2024.02.002
摘要
Breast cancer (BC) treatment with anthracyclines and/or anti-human epidermal growth factor receptor-2 (HER2) antibodies is associated with an increased risk of cardiovascular disease complications, including cancer therapy-related cardiac dysfunction (CTRCD). While Cardio-Oncology Rehabilitation (CORe) programs including exercise have emerged to minimize these risks, its role in preventing CTRCD is unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI